Balchem Corp

BCPC

Market cap $4.64B

Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

MONTVALE, N. J.--(BUSINESS WIRE)--Balchem, a global manufacturer of specialty ingredients for human nutrition, has launched its first direct-to-consumer initiative.

MONTVALE, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the H.C.

Balchem (BCPC) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.98 per share a year ago.

Balchem (BCPC 0.24%), a leading provider of nutritional ingredients and specialty chemicals, released its second quarter results on July 31, 2025. The key news: Balchem reported record GAAP revenue and non-GAAP profits, well surpassing analyst expectations for Q2 FY2025.

Balchem Corporation (NASDAQ:BCPC ) Q2 2025 Earnings Conference Call July 31, 2025 11:00 AM ET Company Participants Carl Martin Bengtsson - Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health Theodore Lee Harris - CEO, President & Chairman Conference Call Participants Anthony Polak - Unidentified Company Aegis Capital Corp. - Unidentified Company Daniel Scott Harriman - Sidoti & Company, LLC Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Robert James Labick - CJS Securities, Inc. Operator Ladies and gentlemen, thank you for standing by.

Blachem (BCPC) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.98 per share a year ago.

MONTVALE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal second quarter ended June 30, 2025.

MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to review second quarter 2025 results.

Balchem operates in diverse specialty ingredient markets, maintaining steady growth and a market cap of $5.3B. Revenue per share has grown 6% annually over a decade, but recent growth has plateaued, warranting close monitoring. Gross profit margin has improved significantly, rising from 30% to over 35% in the latest fiscal year.